跳至主要内容
临床试验/NCT00497783
NCT00497783已完成4 期

Safety Dermatological Evaluation of the Acceptability With Gynecological Follow up for Dermacyd Femina Delicata

Sanofi1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2007年5月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
30
试验地点
1
主要终点
Clinical and local tolerability

研究概览

简要总结

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Integral skin in the tested region

排除标准

  • Pregnancy or breastfeeding women
  • Use of Anti-inflammatory or immune-suppression drugs
  • Topical medication use at the tested region
  • Active cutaneous gynaecological disease which may interfere in study results
  • Personal history of allergic disease at the area to be treated
  • Allergic or atopic history
  • The above information is not intended to contain considerations relevant to a patient's potential participation in a clinical trial.

结局指标

主要结局

Clinical and local tolerability

时间窗: 21 days

Adverse events and their association with the treatment.

时间窗: 21 days

次要结局

未报告次要终点

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验